Ra Capital Management, L.P. 13F annual report

Ra Capital Management, L.P. is an investment fund managing more than $7.56 trillion ran by Rajeev Shah. There are currently 78 companies in Mr. Shah’s portfolio. The largest investments include Ascendis Pharma A/s - Adr and Vaxcyte, together worth $2 trillion.

Limited to 30 biggest holdings

$7.56 trillion Assets Under Management (AUM)

As of 7th August 2024, Ra Capital Management, L.P.’s top holding is 10,108,400 shares of Ascendis Pharma A/s - Adr currently worth over $1.38 trillion and making up 18.2% of the portfolio value. In addition, the fund holds 8,203,754 shares of Vaxcyte worth $619 billion, whose value grew 3.5% in the past six months. The third-largest holding is Janux Therapeutics Inc worth $384 billion and the next is Legend Biotech Corp-adr worth $332 billion, with 7,506,934 shares owned.

Currently, Ra Capital Management, L.P.'s portfolio is worth at least $7.56 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Ra Capital Management, L.P.

The Ra Capital Management, L.P. office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Rajeev Shah serves as the Authorized Signatory at Ra Capital Management, L.P..

Recent trades

In the most recent 13F filing, Ra Capital Management, L.P. revealed that it had opened a new position in Recursion Pharmaceuticals-a and bought 15,384,615 shares worth $115 billion.

The investment fund also strengthened its position in Legend Biotech Corp-adr by buying 645,837 additional shares. This makes their stake in Legend Biotech Corp-adr total 7,506,934 shares worth $332 billion.

On the other hand, there are companies that Ra Capital Management, L.P. is getting rid of from its portfolio. Ra Capital Management, L.P. closed its position in Inhibrx on 14th August 2024. It sold the previously owned 2,629,837 shares for $91.9 billion. Rajeev Shah also disclosed a decreased stake in Apogee Therapeutics Inc by approximately 0.1%. This leaves the value of the investment at $77.2 billion and 1,961,863 shares.

One of the largest hedge funds

The two most similar investment funds to Ra Capital Management, L.P. are Tortoise Capital Advisors, L.L.C and Synovus Financial Corp. They manage $7.56 trillion and $7.55 trillion respectively.


Rajeev Shah investment strategy

Ra Capital Management, L.P.’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 33.0% of the total portfolio value. The fund focuses on investments in the United States as 30.8% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 3% of the total holdings value. On the other hand, large-cap stocks make up only 1.3% of the portfolio. The average market cap of the portfolio companies is close to $2.52 billion.

The complete list of Ra Capital Management, L.P. trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Ascendis Pharma A/s - Adr
No change
10,108,400
$1,378,583,592,000 18.23%
Vaxcyte, Inc.
No change
8,203,754
$619,465,465,000 8.19%
Janux Therapeutics Inc
No change
9,165,652
$383,949,162,000 5.08%
Legend Biotech Corp-adr
9.41%
7,506,934
$332,482,107,000 4.40%
Rhythm Pharmaceuticals Inc.
14.15%
6,084,412
$249,825,957,000 3.30%
Biogen Inc
32.59%
982,139
$227,679,463,000 3.01%
Eliem Therapeutics Inc
138.91%
31,419,267
$223,390,988,000 2.95%
Rxsight Inc
7.32%
3,694,825
$222,317,620,000 2.94%
Avidity Biosciences, Inc.
64.54%
5,400,408
$220,606,667,000 2.92%
Dyne Therapeutics, Inc.
22.09%
6,049,204
$213,476,409,000 2.82%
Geron Corp.
No change
46,202,425
$195,898,282,000 2.59%
Pepgen Inc
No change
10,689,545
$170,605,138,000 2.26%
Tyra Biosciences Inc
No change
10,416,609
$166,561,578,000 2.20%
Evolent Health Inc - A
48.44%
8,514,862
$162,804,161,000 2.15%
Edgewise Therapeutics Inc
No change
8,909,091
$160,452,729,000 2.12%
Newamsterdam Pharma Co Nv
2.54%
8,064,000
$154,909,440,000 2.05%
Recursion Pharmaceuticals-a
Opened
15,384,615
$115,384,613,000 1.53%
89bio Inc
11.03%
14,175,398
$113,544,938,000 1.50%
Verona Pharma Plc - Adr
20.81%
7,632,646
$110,368,061,000 1.46%
Day One Biopharmaceuticals I
0.79%
7,871,721
$108,472,315,000 1.43%
4d Molecular Therapeutics In
0.92%
5,098,211
$107,011,449,000 1.42%
Ars Pharmaceuticals Inc
No change
10,860,977
$92,426,914,000 1.22%
Inhibrx, Inc.
Closed
2,629,837
$91,939,102,000
Wave Life Sciences Ltd.
No change
18,202,009
$90,828,025,000 1.20%
Longboard Pharmaceuticals In
No change
3,289,119
$88,904,887,000 1.18%
Arcellx Inc
Opened
1,604,014
$88,525,533,000 1.17%
Axsome Therapeutics Inc
No change
1,000,000
$80,500,000,000 1.06%
Apogee Therapeutics Inc
0.81%
1,961,863
$77,199,309,000 1.02%
Gh Research Plc
5.60%
6,601,689
$76,975,694,000 1.02%
Structure Therapeutics Inc
25.58%
1,896,772
$74,486,236,000 0.99%
Lenz Therapeutics Inc
No change
4,178,823
$72,251,850,000 0.96%
Fulcrum Therapeutics Inc
No change
11,609,704
$71,980,165,000 0.95%
Nkarta, Inc.
No change
10,805,129
$63,858,312,000 0.84%
Dianthus Therapeutics Inc
No change
2,333,000
$60,378,040,000 0.80%
Mineralys Therapeutics Inc
No change
4,850,984
$56,756,513,000 0.75%
Madrigal Pharmaceuticals Inc
Closed
204,500
$54,609,680,000
iTeos Therapeutics, Inc.
20.37%
3,517,259
$52,196,124,000 0.69%
UroGen Pharma Ltd
No change
3,083,430
$51,739,955,000 0.68%
Praxis Precision Medicines I
49.16%
1,235,599
$51,104,375,000 0.68%
Enliven Therapeutics Inc
No change
2,122,465
$49,602,007,000 0.66%
Acrivon Therapeutics Inc
73.38%
8,340,508
$48,374,946,000 0.64%
Astria Therapeutics Inc
14.29%
5,043,756
$45,898,180,000 0.61%
Cytek Biosciences Inc
Closed
6,809,404
$45,691,101,000
Bicycle Therapeutics Plc-adr
181.63%
2,253,000
$45,600,720,000 0.60%
Cg Oncology Inc
No change
1,397,433
$44,116,960,000 0.58%
Larimar Therapeutics, Inc.
No change
6,045,351
$43,828,795,000 0.58%
Acumen Pharmaceuticals Inc
No change
14,932,063
$36,135,592,000 0.48%
Tourmaline Bio Inc
Opened
2,538,925
$32,650,576,000 0.43%
Third Harmonic Bio Inc
No change
2,033,056
$26,429,728,000 0.35%
Solid Biosciences Inc
No change
4,330,446
$24,553,629,000 0.32%
Taysha Gene Therapies, Inc.
No change
10,872,503
$24,354,407,000 0.32%
Tenaya Therapeutics Inc
32.45%
7,622,347
$23,629,276,000 0.31%
Vor Biopharma Inc
No change
22,748,880
$22,748,880,000 0.30%
C4 Therapeutics, Inc.
No change
4,878,000
$22,536,360,000 0.30%
Alto Neuroscience Inc
50.53%
2,085,554
$22,294,572,000 0.29%
Immatics Nv
No change
1,750,000
$20,335,000,000 0.27%
Vaxart Inc
Closed
15,384,615
$20,000,000,000
EyePoint Pharmaceuticals Inc
Closed
938,591
$19,400,676,000
Sera Prognostics Inc-a
49.83%
3,032,808
$17,954,223,000 0.24%
Black Diamond Therapeutics I
Closed
3,525,754
$17,875,573,000
Aerovate Therapeutics Inc
11.23%
9,192,092
$15,258,873,000 0.20%
Werewolf Therapeutics Inc
No change
6,144,881
$14,993,510,000 0.20%
Cervomed Inc
5.16%
817,120
$13,989,094,000 0.19%
Pliant Therapeutics, Inc.
No change
1,281,000
$13,770,750,000 0.18%
Nurix Therapeutics, Inc.
Opened
650,000
$13,565,500,000 0.18%
Insmed Inc
Opened
200,000
$13,400,000,000 0.18%
An2 Therapeutics Inc
No change
5,551,295
$11,935,284,000 0.16%
Cybin Inc
24.31%
44,004,464
$11,925,210,000 0.16%
Zura Bio Ltd
Opened
3,217,503
$11,261,261,000 0.15%
Arvinas Inc
No change
421,348
$11,216,284,000 0.15%
Regulus Therapeutics Inc
No change
6,250,000
$11,156,250,000 0.15%
Lexeo Therapeutics Inc
1.78%
672,712
$10,790,300,000 0.14%
Adicet Bio Inc
No change
7,541,000
$9,124,610,000 0.12%
Nuvalent Inc-a
Opened
119,789
$9,087,194,000 0.12%
IGM Biosciences, Inc.
Closed
937,500
$9,046,875,000
Macrogenics Inc
No change
2,082,021
$8,848,589,000 0.12%
Boundless Bio Inc
No change
2,180,631
$8,439,042,000 0.11%
Chimerix Inc
No change
8,800,000
$7,708,800,000 0.10%
Perceptive Capital Solutions
Opened
750,000
$7,545,000,000 0.10%
COMPASS Pathways plc
Closed
791,359
$6,584,107,000
Metagenomi Inc
15.29%
1,477,749
$6,029,216,000 0.08%
Curevac Nv
Closed
1,965,707
$5,956,092,000
Protara Therapeutic Inc
Opened
1,900,000
$3,952,000,000 0.05%
Surrozen Inc
Opened
282,580
$3,094,251,000 0.04%
Newamsterdam Pharma Co Nv-27
No change
333,333
$2,906,664,000 0.04%
Unicycive Therapeutics Inc
24.16%
2,632,200
$1,318,995,000 0.02%
Scilex Holding Co
Opened
261,179
$504,075,000 0.01%
No transactions found
Showing first 500 out of 87 holdings